These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25093381)

  • 41. Another case of myelodysplasia with monosomy 7 following fludarabine-based chemotherapy.
    Murphy PT; Mitra S; O'Donghaile D
    Am J Hematol; 2006 Jun; 81(6):473. PubMed ID: 16680754
    [No Abstract]   [Full Text] [Related]  

  • 42. Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate.
    Espinet B; Oliveira AC; Boqué C; Domingo A; Alonso E; Solé F
    Haematologica; 2005 Apr; 90(4):556-8. PubMed ID: 15820956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cutaneous adverse reaction to imatinib in a case of childhood chronic myeloid leukemia.
    Saroha M
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28490. PubMed ID: 32573963
    [No Abstract]   [Full Text] [Related]  

  • 45. Cystic acne due to imatinib therapy for chronic myelocytic leukemia.
    Hwang A; Iskandar A; Del Rosario M; Dasanu CA
    J Oncol Pharm Pract; 2019 Jun; 25(4):972-974. PubMed ID: 29498323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate.
    Schoch C; Haferlach T; Kern W; Schnittger S; Berger U; Hehlmann R; Hiddemann W; Hochhaus A
    Leukemia; 2003 Feb; 17(2):461-3. PubMed ID: 12592348
    [No Abstract]   [Full Text] [Related]  

  • 47. Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.
    Bonifacio M; Binotto G; Maino E; Calistri E; Marin L; Scaffidi L; Frison L; De Marchi F; Krampera M; Semenzato G; Fanin R; Ambrosetti A; Tiribelli M;
    Haematologica; 2015 Aug; 100(8):e299-301. PubMed ID: 25820333
    [No Abstract]   [Full Text] [Related]  

  • 48. Clonal evolution in Philadelphia chromosome negative cells following successful treatment with Imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome.
    Alimena G; Breccia M; Mancini M; Ferranti G; De Felice L; Gallucci C; Mandelli F
    Leukemia; 2004 Feb; 18(2):361-2. PubMed ID: 14614517
    [No Abstract]   [Full Text] [Related]  

  • 49. Imatinib mesylate induced erythroderma: A rare case series.
    Kumar S; Mahajan BB; Kaur S; Banipal RP; Singh A
    J Cancer Res Ther; 2015; 11(4):993-6. PubMed ID: 26881566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosome abnormalities in myelodysplastic syndromes.
    Nowell PC
    Semin Oncol; 1992 Feb; 19(1):25-33. PubMed ID: 1736367
    [No Abstract]   [Full Text] [Related]  

  • 51. Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate.
    Hardling M; Wei Y; Palmqvist L; Swolin B; Stockelberg D; Gustavsson B; Ekeland-Sjöberg K; Wadenvik H; Ricksten A
    Med Oncol; 2004; 21(4):349-58. PubMed ID: 15579919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib.
    Meeus P; Demuynck H; Martiat P; Michaux L; Wouters E; Hagemeijer A
    Leukemia; 2003 Feb; 17(2):465-7. PubMed ID: 12592350
    [No Abstract]   [Full Text] [Related]  

  • 53. A Large Gray-Blue Macule on the Hard Palate as an Adverse Effect of Imatinib.
    Lueken N; Kaune KM; Zutt M
    Dtsch Arztebl Int; 2019 Feb; 116(6):95. PubMed ID: 30892185
    [No Abstract]   [Full Text] [Related]  

  • 54. Newly diagnosed breast cancer in a patient receiving imatinib mesylate.
    Kaygusuz-Atagunduz I; Toptas T; Yumuk F; Firatli-Tuglular T; Bayik M
    J Cancer Res Ther; 2014; 10(4):1107-8. PubMed ID: 25579564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Additional rearrangements affecting the derivative chromosome 9 involved in the standard Philadelphia translocation after imatinib therapy in a patient with chronic myeloid leukemia.
    Wang HP; Chen ZM; Lou JY; Xu H; Yu YB; Jin J
    Cancer Genet Cytogenet; 2008 Apr; 182(1):63-4. PubMed ID: 18328955
    [No Abstract]   [Full Text] [Related]  

  • 56. [Secondary myelodysplastic syndrome with monosomy 7].
    Inokuchi K; Tajika K; Ito T; Ogata K; Yamada T; Tanabe Y; Ohki I; Dan K; Kuriya S; Nomura T
    Rinsho Ketsueki; 1988 May; 29(5):718-22. PubMed ID: 3216498
    [No Abstract]   [Full Text] [Related]  

  • 57. Isodicentric Philadelphia chromosomes in imatinib mesylate (Gleevec)-resistant patients.
    Szych CM; Liesveld JL; Iqbal MA; Li L; Siebert S; Asmus C; O'Malley J; Lee A; Wang N
    Cancer Genet Cytogenet; 2007 Apr; 174(2):132-7. PubMed ID: 17452255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine.
    Itzykson R; Thépot S; Eclache V; Quesnel B; Dreyfus F; Beyne-Rauzy O; Turlure P; Vey N; Recher C; Boehrer S; Gardin C; Adès L; Fenaux P;
    Leukemia; 2011 Jul; 25(7):1207-9. PubMed ID: 21468040
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Philadelphia-positive chronic myeloid leukemia with del(7)(p11p15).
    Zámecníková A; Gyárfás J; Krizan P; Weismanová E
    Cancer Genet Cytogenet; 1996 Oct; 91(1):88-90. PubMed ID: 8908175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.